Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
108.81
+1.37 (+1.28%)
Streaming Delayed Price
Updated: 1:25 PM EST, Jan 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Wall Street Holds Firm Despite Shutdown and Weak Jobs Data
↗
October 02, 2025
Stocks shrugged off Washington’s chaos as hopes for Fed rate cuts and strong corporate news kept investors in a buying mood.
Via
Chartmill
Topics
Economy
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years
↗
October 01, 2025
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.
Via
Benzinga
Topics
Government
Why Merck (MRK) Stock Is Up Today
October 01, 2025
Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.
Via
StockStory
Topics
Artificial Intelligence
Government
Wednesday's session: top gainers and losers in the S&P500 index
↗
October 01, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via
Chartmill
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
↗
September 29, 2025
Via
Stocktwits
In today's session, there are S&P500 stocks with remarkable trading volume.
↗
October 01, 2025
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.
Via
Chartmill
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
↗
October 01, 2025
Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.
Via
Benzinga
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30
October 01, 2025
From
Merck & Co., Inc.
Via
Business Wire
Pharmaceutical Tariffs ‘A Light At The End Of The Trump Tunnel’ For Big Pharma, Says Jefferies
↗
September 26, 2025
Via
Stocktwits
Topics
Government
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened
↗
September 25, 2025
Via
Stocktwits
Global Markets Defy Headwinds: Resilient Sentiment Prevails Despite Shutdown Fears
September 30, 2025
As the third quarter of 2025 drew to a close on September 30, global financial markets demonstrated a remarkable display of resilience, largely shrugging off significant geopolitical uncertainties and...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
September 30, 2025
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...
Via
MarketMinute
Topics
Economy
Government
World Trade
What's going on in today's session: S&P500 movers
↗
September 30, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Merck (MRK) Shares Skyrocket, What You Need To Know
September 30, 2025
Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 5.7% in the afternoon session after the company announced positive results from its Phase 3 HYPERION trial for its drug, WINREVAIR™...
Via
StockStory
Topics
Artificial Intelligence
Tech Revolutionizes Cattle Feeding: A Sustainable Future for Livestock Markets
September 30, 2025
The global cattle feeding industry is at a critical juncture, facing mounting pressures from volatile feed costs, stringent environmental regulations, and a persistent labor crunch. In response, a wave...
Via
MarketMinute
Topics
Artificial Intelligence
Climate Change
Emissions
Discover which S&P500 stocks are making waves on Tuesday.
↗
September 30, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients
↗
September 30, 2025
Merck reported Phase 3 results showing Winrevair significantly reduced clinical worsening in pulmonary arterial hypertension patients.
Via
Benzinga
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
September 30, 2025
From
Merck Sharp & Dohme
Via
Business Wire
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
September 29, 2025
Merus N.V. (NASDAQ: MRUS) has become the undisputed top performer in today's market, with its stock price rocketing by an astounding 35.9% following the bombshell announcement of its acquisition by...
Via
MarketMinute
U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears
September 29, 2025
As the clock ticks towards the September 30, 2025, funding deadline, the United States federal government finds itself perilously close to another shutdown. Congressional leaders remain deadlocked on a...
Via
MarketMinute
Topics
Bonds
Economy
Government
Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program
↗
September 29, 2025
The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies to reduce drug prices in the U.S. to the levels paid by other developed countries.
Via
Stocktwits
Topics
Government
Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
September 27, 2025
In a hypothetical scenario playing out just last week, leading up to September 27, 2025, Johnson & Johnson (NYSE: JNJ) experienced a significant stock rally, capturing the attention of investors and...
Via
MarketMinute
Topics
Economy
Intellectual Property
Healthcare Sector Reels: A Deep Dive into Thursday's -1.67% Plunge
September 26, 2025
The healthcare sector experienced a significant downturn on Thursday, September 25, 2025, shedding a notable -1.67% of its value and sending ripples of concern through the broader financial markets....
Via
MarketMinute
Topics
Economy
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
↗
September 26, 2025
Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de
Via
Benzinga
Topics
Government
World Trade
Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now
↗
September 26, 2025
BigBear.ai is bigger than both of these AI-focused companies now. That could change.
Via
The Motley Fool
Topics
Artificial Intelligence
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
↗
September 26, 2025
Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr.
Via
Benzinga
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America
↗
September 25, 2025
Via
Stocktwits
Topics
Government
Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre
↗
September 25, 2025
Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe."
Via
Benzinga
Peering Into Merck & Co's Recent Short Interest
↗
September 25, 2025
Merck & Co's (NYSE: MRK) short interest as a percent of float has risen 16.98% since its last report. According to exchange reported data, there are now 27.71 million shares sold short, which is 1.24%...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
